Abbvie Accuses Takeda of Failing to Meet Lupron Supply Agreement

(Bloomberg) -- A unit of Abbvie Inc. accused Japanese drugmaker Takeda Pharmaceutical Co. of failing to produce enough of the cancer drug Lupron to fulfill a supply agreement.Officials of AbbVie En...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.